Pictet Asset Management Holding Sa Madrigal Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 150,598 shares of MDGL stock, worth $46.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
150,598
Previous 137,275
9.71%
Holding current value
$46.8 Million
Previous $38.5 Million
16.9%
% of portfolio
0.04%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding MDGL
# of Institutions
297Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$770 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$635 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$631 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$620 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$614 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.32B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...